Özet:

Cardiovascular diseases (KVH) are the leading cause of mortality and morbidity in diabetes mellitus, and diabetes is a metabolic disorder that is also seen equal to KVH. Treatment of dyslipidemia in diabetic patients is very important for these reasons and the guidelines recommend statin therapy primarily to reach the target low-intensity lipoprotein cholesterol (LDL-K) levels. In this study, we have studied the stain use of patients applying to a third-level health center and the rates of achieving the target LDL-K level. Materials and Methods: 210 patients with DM diagnosis, which were applied to the cardiology clinic within 3 months of study, were taken. The target LDL-K level is defined as <70 mg/dL if there is a KVH history, secondary micro- and macrovascular complications to the DM, if there is one or more cardiovascular risk factors over the age of 40; if there is an additional risk factor or target organ damage, if there is a reduction of <100 mg/dL and if there is a reduction of at least 50% in the LDL-K value starting with statin treatment. Results: The average age of patients was 53.8±15,1 and 64.3% (n=135) women. In patients who did not use statin (n=140), 83.6% of patients (n=117) were not at the target level. 87.1% of patients using statin (n=61) were not able to reach the target LDL-K level. 1.4% of these patients (n=1) used low-intensity, 87.1% (n=61) medium-intensity and 11.4% (n=8) high-intensity statins. The result: Our study has shown that most diabetic patients have not reached their target LDL-K levels. This condition is due to the fact that both the medication is not sufficiently initiated by the doctors, the treatment is not regulated according to the LDL-K level when it begins, and the patients are not regularly taking the medication. According to the study, the importance of statin therapy is to be told to individuals.

Anahtar Kelimeler: